This HIF-1-dependent mechanism appears to allow a part of cancer cells to leave the site undergoing serial therapeutic irradiation to form distant metastases in other tissues and organs, therefore nullifying the outcome of radiotherapy (Figure 2). The gene discussed is HIF1A; the disease is cancer.